12H·

$COR (-0,28 %)

I am invested and the share has achieved good results. Analysts tend to recommend buying. According to sites like aktienfinder, there is an overvaluation that the share could grow into. But what is your general assessment? Is the economic performance weakening? Has anyone already sold a share? Will there be laws in the future to sustainably reduce healthcare costs? A law that is aimed more at the mediation structure is in the works

Participez à la conversation